Personalis Income After Taxes 2018-2024 | PSNL
Personalis income after taxes from 2018 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Personalis Annual Income After Taxes
(Millions of US $) |
| 2023 |
$-108 |
| 2022 |
$-113 |
| 2021 |
$-65 |
| 2020 |
$-41 |
| 2019 |
$-25 |
| 2018 |
$-20 |
| 2017 |
$-24 |
Personalis Quarterly Income After Taxes
(Millions of US $) |
| 2024-09-30 |
$-39 |
| 2024-06-30 |
$-13 |
| 2024-03-31 |
$-13 |
| 2023-12-31 |
$-27 |
| 2023-09-30 |
$-29 |
| 2023-06-30 |
$-24 |
| 2023-03-31 |
$-29 |
| 2022-12-31 |
$-31 |
| 2022-09-30 |
$-26 |
| 2022-06-30 |
$-28 |
| 2022-03-31 |
$-28 |
| 2021-12-31 |
$-20 |
| 2021-09-30 |
$-18 |
| 2021-06-30 |
$-15 |
| 2021-03-31 |
$-12 |
| 2020-12-31 |
$-13 |
| 2020-09-30 |
$-10 |
| 2020-06-30 |
$-9 |
| 2020-03-31 |
$-9 |
| 2019-12-31 |
$-7 |
| 2019-09-30 |
$-7 |
| 2019-06-30 |
$-6 |
| 2019-03-31 |
$-6 |
| 2018-12-31 |
|
| 2018-09-30 |
$-4 |
| 2018-06-30 |
$-7 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.261B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
